Organisation paid for research Program year 2021 Source: CMS Open Payments

Verity Research

Neither a doctor nor a teaching hospital

Research payments

$18,427

5 payments

Through program year 2021, Verity Research is reported as receiving $18,427 in research payments, across 5 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$8,581	3
2020	Research	$9,500	1
2019	Research	$346	1

Breakdown

Who paid Research payments · program years 2019–2021

AstraZeneca Pharmaceuticals LP $13,200 2 payments
Pfizer Inc. $5,227 3 payments

Studies the money was for Research payments · program years 2019–2021

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) $13,200 2 payments
A Phase 2B Multicenter Randomized Doubleblind Placebocontrolled Doseranging Study to Evaluate the Efficacy Safety and Pharmacokinetics of Pf06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis $4,881 2 payments
A Phase 2B Doubleblind Randomized Placebocontrolled Parallel Group Dose Ranging Study of Oral Pf06651600 and Pf06700841 As Induction and Chronic Therapy in Subjects With Moderate to Severe Ulcerative Colitis $346 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.